New hope for myelofibrosis patients: experimental drug KER-050 enters phase 2 trial
NCT ID NCT05037760
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 33 times
Summary
This study tests a new drug called elritercept (KER-050) in about 135 adults with myelofibrosis, a rare bone marrow cancer. The drug is given alone or with the standard medicine ruxolitinib. The main goals are to check safety and see if it helps with anemia and other symptoms. This is not a cure, but aims to control the disease and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center
RECRUITINGMilan, Italy
Contact
Contact
-
Albert Einstein Sociedade Beneficente Israelita Brasiliera
RECRUITINGSão Paulo, Brazil
Contact
Contact
-
Arcispedale S. Maria Nuova Azienda Ospedaliera di Reggio Emilia
RECRUITINGReggio Emilia, Italy
Contact
Contact
-
Azienda Ospedaliera Universitaria Careggi
RECRUITINGFlorence, Italy
Contact
Contact
-
Azienda Ospedaliera Universitaria Integrata Verona
RECRUITINGVerona, Italy
Contact
Contact
-
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi
RECRUITINGBologna, Italy
Contact
Contact
-
Azienda Ospedaliera Universitaria Policlinico Umberto I
RECRUITINGRoma, Italy
Contact
Contact
-
Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari
RECRUITINGBari, Italy
Contact
Contact
-
Azienda Socio Sanitaria Territoriale Sette Laghi
RECRUITINGVarese, Italy
Contact
Contact
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
RECRUITINGBrescia, Italy
Contact
Contact
-
Ballarat Oncology & Haematology Service
RECRUITINGWendouree, Victoria, 3355, Australia
Contact
Contact
-
CHU Amiens - Hopital Sud
COMPLETEDAmiens, France
-
Centre Hospitalier Lyon Sud
RECRUITINGLyon, France
Contact
Contact
-
Concord Hospital
RECRUITINGConcord, New South Wales, Australia
Contact
Contact
-
Flinders Medical Centre
RECRUITINGWoodville South, South Australia, 5042, Australia
Contact
Contact
-
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
RECRUITINGMilan, Italy
Contact
Contact
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
COMPLETEDMilan, Italy
-
Gachon University Gil Medical Center
COMPLETEDIncheon, South Korea
-
Guys Hospital
RECRUITINGLondon, United Kingdom
Contact
Contact
-
Hammersmith Hospital
RECRUITINGLondon, United Kingdom
Contact
Contact
-
Hopital Morvan
COMPLETEDBrest, France
-
Hopital Prive Sevigne
COMPLETEDCesson-Sévigné, France
-
Hopital de la Source - CHR Orleans
COMPLETEDOrléans, France
-
Hospital Beneficencia Portuguesa de Sao Paulo
RECRUITINGSão Paulo, Brazil
Contact
Contact
-
Hospital Clinico Universitario de Valencia
RECRUITINGValencia, Spain
Contact
Contact
-
Hospital Das Clinicas Da Faculdade de Medicina Da U S P
RECRUITINGSão Paulo, Brazil
Contact
Contact
-
Hospital QuironSalud de Zaragoza
RECRUITINGZaragoza, Spain
Contact
Contact
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, Spain
Contact
Contact
-
Hospital Universitario La Paz
RECRUITINGMadrid, Spain
Contact
Contact
-
Hospital Universitario La Princesa
RECRUITINGMadrid, Spain
Contact
Contact
-
Hospital Universitario de Salamanca
RECRUITINGSalamanca, Spain
Contact
Contact
-
Hospital de Clinicas de Porto Alegre
RECRUITINGPorto Alegre, Brazil
Contact
Contact
-
ICO Badalona - Hospital Universitari Germans Trias i Pujol
RECRUITINGBadalona, Spain
Contact
Contact
-
IMV-Pesquisa Cardiologica Sociedade Simples
RECRUITINGPorto Alegre, Brazil
Contact
Contact
-
Institut de Cancerologie du Gard
RECRUITINGNîmes, France
Contact
Contact
-
Instituto de Ensino e Pesquisas Sao Lucas
RECRUITINGSão Paulo, Brazil
Contact
Contact
-
Ospedale Policlinico San Martino
RECRUITINGGenova, Italy
Contact
Contact
-
Royal Melbourne Hospital
RECRUITINGMelbourne, Victoria, 3050, Australia
Contact
Contact
-
Samsung Medical Center
COMPLETEDSeoul, South Korea
-
Seoul St. Marys Hospital, The Catholic University of Korea
RECRUITINGSeoul, South Korea
Contact
Contact
-
Soonchunhyang University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact
Contact
-
St James Hospital,Leeds
RECRUITINGLeeds, United Kingdom
Contact
Contact
-
St. Vincents Hospital Melbourne
RECRUITINGFitzroy, Victoria, 3355, Australia
Contact
Contact
-
The Tweed Hospital
RECRUITINGTweed Heads, New South Wales, 2485, Australia
Contact
Contact
-
United Lincolnshire Hospitals NHS Trust - Pilgrim Hospital
RECRUITINGBoston, United Kingdom
Contact
Contact
-
University College London
RECRUITINGLondon, United Kingdom
Contact
Contact
Conditions
Explore the condition pages connected to this study.